TechnoPhage, SA - From science to innovative biopharmaceuticals
TechnoPhage and SIMM signed a collaboration agreement, announced at AICEP Portugal Global, involving a collaboration in both pre-clinical and future clinical studies of TA101 for the treatment of Rheumatoid Arthritis to market TA101 in the People's Republic of China.
TechnoPhage invited to present at conference "Inovação Biofarmacêutica: por uma Europa mais competitiva" organized by the Câmara de Comércio Luso-Belga-Luxemburguesa and UCB Pharma

2019 events

Phage Futures Europe
Brussels, Belgium, September 25-26, 2019